GSK3β-IN-1
GSK3β-IN-1 (compound 1) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=65 nM), which can be used in the study of Alzheimer's disease[1].
Product Specifications
CAS Number
757198-76-8
UNSPSC
12352005
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Neurological Disease
Smiles
FC1=CC(CSC2=NN=C(C3=CC4=C(OCO4)C=C3)O2)=CC=C1OC
Molecular Formula
C17H13FN2O4S
Molecular Weight
360.36
References & Citations
[1]Saitoh M, et al. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta. Bioorg Med Chem. 2009 Mar 1;17 (5) :2017-29.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740950-500 1x 500 µL
MiTF (Microphthalmia Transcription Factor) (D5 + MITF/915), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC683026-500 1x 500 µL
CD4 (T-Helper/Inducer Cell Marker) (CD4/3026), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471696-100 1x 100 µL
CTLA4 / CD152 (Negative Regulator of T-Cells) (L4P2F5.F10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details